Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions.

Brito-Zerón P, Sisó-Almirall A, Bové A, Kostov BA, Ramos-Casals M.

Expert Opin Pharmacother. 2013 Feb;14(3):279-89. doi: 10.1517/14656566.2013.767333. Epub 2013 Jan 25. Review.

PMID:
23346917
[PubMed - indexed for MEDLINE]
2.

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X, Tzioufas AG.

Nat Rev Rheumatol. 2012 May 1;8(7):399-411. doi: 10.1038/nrrheum.2012.53.

PMID:
22549247
[PubMed - indexed for MEDLINE]
3.

[Current therapeutic options in Sjögren's syndrome].

Hansen A, Dörner T.

Z Rheumatol. 2010 Feb;69(1):19-24. doi: 10.1007/s00393-009-0515-6. Review. German.

PMID:
20013285
[PubMed - indexed for MEDLINE]
4.

Management of patients presenting with Sjogren's syndrome.

Venables PJ.

Best Pract Res Clin Rheumatol. 2006 Aug;20(4):791-807. Review.

PMID:
16979538
[PubMed - indexed for MEDLINE]
5.

Sjögren's syndrome: current therapies remain inadequate for a common disease.

Fox RI.

Expert Opin Investig Drugs. 2000 Sep;9(9):2007-16. Review.

PMID:
11060789
[PubMed - indexed for MEDLINE]
6.

Treatment of primary Sjögren syndrome: a systematic review.

Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X.

JAMA. 2010 Jul 28;304(4):452-60. doi: 10.1001/jama.2010.1014. Review.

PMID:
20664046
[PubMed - indexed for MEDLINE]
7.

[Current treatments of xerophthalmia in Sjögren's syndrome].

Baudouin C, Pisella PJ, Brignole F.

Rev Med Interne. 2004 May;25(5):376-82. Review. French.

PMID:
15110955
[PubMed - indexed for MEDLINE]
8.

Punctal occlusion in Sjögren's syndrome needs clarification.

Rocha EM, Paula JS, Reinach PS.

Nat Rev Rheumatol. 2012 Dec;8(12):752; author reply 752. doi: 10.1038/nrrheum.2012.53-c1. Epub 2012 Oct 23. No abstract available.

PMID:
23090509
[PubMed - indexed for MEDLINE]
9.

Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.

Nelson JD, Friedlaender M, Yeatts RP, Yee R, McDermott M, Orlin S, Gallagher SC, Shrotriya RC.

Adv Exp Med Biol. 1998;438:979-83. No abstract available.

PMID:
9634998
[PubMed - indexed for MEDLINE]
10.

Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.

Fox RI, Dixon R, Guarrasi V, Krubel S.

Lupus. 1996 Jun;5 Suppl 1:S31-6.

PMID:
8803908
[PubMed - indexed for MEDLINE]
11.

Primary Sjogren's syndrome: current and prospective therapies.

Thanou-Stavraki A, James JA.

Semin Arthritis Rheum. 2008 Apr;37(5):273-92. Epub 2007 Aug 21. Review.

PMID:
17714766
[PubMed - indexed for MEDLINE]
12.

The therapy of Sjogren's syndrome: a review.

Coaccioli S, Giuliani M, Puxeddu A.

Clin Ter. 2007 Sep-Oct;158(5):453-6. Review.

PMID:
18062353
[PubMed - indexed for MEDLINE]
13.

The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome.

Saraux A.

Autoimmun Rev. 2010 Jul;9(9):609-14. doi: 10.1016/j.autrev.2010.05.007. Epub 2010 May 7. Review.

PMID:
20452466
[PubMed - indexed for MEDLINE]
14.

The management of Sjögren's syndrome.

Mavragani CP, Moutsopoulos NM, Moutsopoulos HM.

Nat Clin Pract Rheumatol. 2006 May;2(5):252-61. Review.

PMID:
16932698
[PubMed - indexed for MEDLINE]
15.

Conventional therapy of Sjogren's syndrome.

Mavragani CP, Moutsopoulos HM.

Clin Rev Allergy Immunol. 2007 Jun;32(3):284-91. Review.

PMID:
17992595
[PubMed - indexed for MEDLINE]
16.

Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.

Kono I, Matsumoto Y, Kono K, Ishibashi Y, Narushima K, Kabashima T, Yamane K, Sakurai T, Kashiwagi H.

J Rheumatol. 1985 Jun;12(3):487-9.

PMID:
4045849
[PubMed - indexed for MEDLINE]
18.

Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Ng KP, Isenberg DA.

Drugs Aging. 2008;25(1):19-33. Review.

PMID:
18184026
[PubMed - indexed for MEDLINE]
19.

Prospective studies on the progress of sicca symptoms in Sjögren's syndrome: subclinical disease develops into the clinical syndrome.

Ichikawa Y, Takaya M, Uchiyama M, Shimizu H, Tokunaga M, Saitoh H, Arimori S.

Tokai J Exp Clin Med. 1988 Jun;13(2):85-90.

PMID:
3250005
[PubMed - indexed for MEDLINE]
20.

Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.

Marsh P, Pflugfelder SC.

Ophthalmology. 1999 Apr;106(4):811-6.

PMID:
10201607
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk